- Home
- DAVA vs CBLL Comparison
DAVA vs CBLL Comparison
Compare DAVA & CBLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVA
- CBLL
- Stock Information
- Founded
- DAVA 2000
- CBLL 2014
- Country
- DAVA United Kingdom
- CBLL United States
- Employees
- DAVA N/A
- CBLL N/A
- Industry
- DAVA EDP Services
- CBLL
- Sector
- DAVA Technology
- CBLL
- Exchange
- DAVA Nasdaq
- CBLL Nasdaq
- Market Cap
- DAVA 509.6M
- CBLL 433.7M
- IPO Year
- DAVA 2018
- CBLL 2024
- Fundamental
- Price
- DAVA $9.48
- CBLL $12.88
- Analyst Decision
- DAVA Buy
- CBLL Strong Buy
- Analyst Count
- DAVA 9
- CBLL 7
- Target Price
- DAVA $22.89
- CBLL $30.67
- AVG Volume (30 Days)
- DAVA 952.7K
- CBLL 258.5K
- Earning Date
- DAVA 11-11-2025
- CBLL 11-04-2025
- Dividend Yield
- DAVA N/A
- CBLL N/A
- EPS Growth
- DAVA 24.14
- CBLL N/A
- EPS
- DAVA 0.49
- CBLL N/A
- Revenue
- DAVA $1,058,028,497.00
- CBLL $77,419,000.00
- Revenue This Year
- DAVA N/A
- CBLL $35.45
- Revenue Next Year
- DAVA $3.81
- CBLL $28.18
- P/E Ratio
- DAVA $19.18
- CBLL N/A
- Revenue Growth
- DAVA 4.25
- CBLL 42.16
- 52 Week Low
- DAVA $8.17
- CBLL $10.01
- 52 Week High
- DAVA $34.94
- CBLL $32.75
- Technical
- Relative Strength Index (RSI)
- DAVA 50.31
- CBLL 54.34
- Support Level
- DAVA $8.55
- CBLL $12.54
- Resistance Level
- DAVA $9.03
- CBLL $13.86
- Average True Range (ATR)
- DAVA 0.37
- CBLL 0.67
- MACD
- DAVA 0.15
- CBLL 0.09
- Stochastic Oscillator
- DAVA 84.31
- CBLL 58.52
About DAVA Endava plc (each representing one)
Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the UK, and it continues to generate the majority of revenue in the UK and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.
About CBLL CeriBell Inc.
CeriBell Inc is a commercial-stage medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions. The Company has developed the Ceribell System, a novel, point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining proprietary, portable and rapidly deployable hardware with sophisticated artificial intelligence (AI) powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions.